Nymox Pharma (NYMX) Begins Recruiting for NX-1207 on BPH Phase 3
Tweet Send to a Friend
Nymox Pharmaceutical Corp (NASDAQ: NYMX) that recruitment will begin for NX02-0022, an open-label study of NX-1207, the Company's Phase 3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
